Ping An Healthcare and Technology Company Limited

Ping An Health reported 2021 total revenue of RMB7.334 billion, up about 7% year on year. Medical Services revenue was RMB2.288 billion, up 8% YoY, and represented 31.2% of revenue, up 0.3 percentage point YoY. Medical Services gross margin was 36.1%, while Health Services gross margin was 17.5%. Management also said expense ratio in the second half of the year fell 7% month on month, and overall profit was reduced 10% year on year in the second half. On operating metrics, the company cited 420 million accumulated registered users, 1.27 billion cumulative consultations, more than 38 million cumulative paying users, and 2021 paying-user conversion of 24.8%. Looking ahead, management did not give formal numeric revenue or profit guidance, but said the strategy upgrade would continue, investments would keep going though at a lower level than before, and the company aims to deepen HMO Plus, O2O Plus, Family Doctor, and enterprise/insurance channel expansion.

CEO Fang Weihao framed 2021 as the first year of a major strategic upgrade toward a more integrated health management model. He said the company is shifting from a pure volume focus to a quality focus, centered on HMO Plus, O2O Plus, and the Family Doctor system, and aimed at solving the full user journey from pre-diagnosis to follow-up care. His tone was constructive and confident, but he repeatedly noted that the transformation is complex, requires SOP discipline, and will take time and continued investment.

CFO Zang Luoqi emphasized that revenue grew to RMB7.334 billion, with Medical Services at RMB2.288 billion and Medical Services revenue mix rising to 31.2%. She highlighted profitability by segment, with Medical Services gross margin at 36.1% and Health Services gross margin at 17.5%, and said the company controlled expenses during the strategic transition, with a 10% year-on-year profit reduction in the second half and a 7% month-on-month decrease in expense ratio in the second half. In Q&A, management added that the board believes the stock is undervalued, that current financial assets and cash flow support buybacks, that more than 56 million shares would be repurchased, and that more than RMB500 million had already been spent on buybacks after the annual report was issued.

Analysts asked whether stricter Internet medical regulation would hurt the business; management said it welcomes the rules, arguing that Ping An Health already had compliance systems in place, including quality control, real-name consultation and prescriptions, 12 internet hospitals, and AI-assisted tools. Questions also focused on HMO business progress, with management saying HMO Plus, O2O Plus, and Family Doctor were launched in October and are being rolled out through Ping An Life, Ping An Property & Casualty, and enterprise channels. On profitability and breakeven, management said the new model is long and complex, will require continued investment, and did not commit to a near-term breakeven date.